MYRIAD GENETICS INC MYGN 35.03
Health Care · NASDAQ · Data as of 2026-07-31
MYRIAD GENETICS INC (MYGN) has delivered +0.5% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1678 of 1968 stocks overall and #214 of 260 in the Health Care sector by Steady Score.
Industry
Diagnostic Substances
Steady Score
35.03
Overall Rank
#1678 / 1968
Sector Rank
#214 / 260
Revenue CAGR
+0.5%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio